13D Filing: Billionaire Lei Zhang’s Hillhouse Capital Management Reports Stake in Beigene, Ltd. (BGNE)

Beigene Ltd (ADR) (NASDAQ:BGNE) has recently been included in a 13D filed by billionaire Lei Zhang‘s Hillhouse Capital Management with the US Securities and Exchange Commission. The filing showed that Hillhouse currently owns around 39.73 million shares of Beigene, which represent 9.29% of the company’s outstanding stock. Beigene is a $911 million biopharmaceutical company that went public at the beginning of February. In addition, Hillhouse said in the filing that its employee Yi Qingqing serves on Beigene’s board of directors.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Hillhouse Capital Management, Ltd 39,726,779 0 39,726,779 0 39,726,779 9.29%
Lei Zhang
Lei Zhang
Hillhouse Capital Management

Page 1 of 5 SEC Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.)*

BeiGene,
Ltd.

(Name of Issuer)

Ordinary
Shares

(Title of Class of Securities)

07725L102

(CUSIP Number)

Richard A.
Hornung

Cayman Corporate Centre, 3rd Floor

18 Fort Street

George Town, Grand Cayman

345-749-8642

With a copy to:

Eleazer N. Klein, Esq.

Schulte Roth & Zabel LLP

919 Third Avenue

New York, NY 10022

(212) 756-2000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

February
8, 2016

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 5 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Beigene Ltd. (NASDAQ:BGNE)